ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

4 hedge funds and large institutions have $4.2M invested in Intra-Cellular Therapies Inc. in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 385 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$12.9K
Name Holding Trade Value Shares
Change
Change in
Stake
VanEck Associates
126
VanEck Associates
New York
Arrowstreet Capital
127
Arrowstreet Capital
Massachusetts
PCM
128
Prelude Capital Management
New York
AIMCA
129
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
KI
130
Kapitalo Investimentos
Brazil
Macquarie Group
131
Macquarie Group
Australia
SCM
132
SCS Capital Management
Massachusetts
SFI
133
Susquehanna Fundamental Investments
Pennsylvania
NYLIM
134
New York Life Investment Management
New York
BFM
135
Boothbay Fund Management
New York
JPMIA
136
J.P. Marvel Investment Advisors
Massachusetts
Ohio Public Employees Retirement System (OPERS)
137
Ohio Public Employees Retirement System (OPERS)
Ohio
AG
138
Algert Global
California
VI
139
Versor Investments
New York
New York State Common Retirement Fund
140
New York State Common Retirement Fund
New York
EPM
141
Equitec Proprietary Markets
Illinois
AC
142
Athos Capital
Hong Kong
AGM
143
Alpine Global Management
New York
EIM
144
Essex Investment Management
Massachusetts
Barclays
145
Barclays
United Kingdom
PAS
146
Point72 Asia (Singapore)
Singapore
ACM
147
ADAR1 Capital Management
Texas
Treasurer of the State of North Carolina
148
Treasurer of the State of North Carolina
North Carolina
WIC
149
Water Island Capital
New York
VOYA Investment Management
150
VOYA Investment Management
Georgia